Intestinal translocation of enterococci requires a threshold level of enterococcal overgrowth in the lumen.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
20 06 2019
20 06 2019
Historique:
received:
11
01
2019
accepted:
06
06
2019
entrez:
22
6
2019
pubmed:
22
6
2019
medline:
3
11
2020
Statut:
epublish
Résumé
Enterococci are subdominant members of the human gastrointestinal microbiota. Enterococcus faecalis is generally harmless for healthy individuals, but it can cause a diverse range of infections in immunodeficient or elderly patients with severe underlying diseases. In this study, we analysed the levels of intestinal translocation of indigenous enterococci in C57BL/6, CF-1 and CX3CR1
Identifiants
pubmed: 31222056
doi: 10.1038/s41598-019-45441-3
pii: 10.1038/s41598-019-45441-3
pmc: PMC6586816
doi:
Substances chimiques
CX3C Chemokine Receptor 1
0
Cx3cr1 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8926Références
Gene. 1996 Dec 12;183(1-2):175-82
pubmed: 8996104
FEMS Microbiol Lett. 2005 Jan 15;242(2):217-9
pubmed: 15621440
Infect Immun. 2005 Mar;73(3):1606-12
pubmed: 15731060
Nat Rev Microbiol. 2012 Mar 16;10(4):266-78
pubmed: 22421879
Cell Microbiol. 2016 Jun;18(6):831-43
pubmed: 26663775
J Bacteriol. 1974 Feb;117(2):360-72
pubmed: 4204433
J Leukoc Biol. 2009 Oct;86(4):999-1005
pubmed: 19622799
Gut. 2016 Jul;65(7):1100-9
pubmed: 26045138
Nat Rev Immunol. 2013 Nov;13(11):790-801
pubmed: 24096337
Plasmid. 2003 May;49(3):281-5
pubmed: 12749839
Antimicrob Agents Chemother. 1988 Dec;32(12):1769-75
pubmed: 3245692
Sci Rep. 2018 Mar 23;8(1):5098
pubmed: 29572473
Circulation. 2003 Feb 25;107(7):1009-16
pubmed: 12600915
J Antimicrob Chemother. 2016 Dec;71(12):3453-3458
pubmed: 27609052
Antimicrob Agents Chemother. 1989 Sep;33(9):1588-91
pubmed: 2554802
PLoS One. 2014 Aug 20;9(8):e105120
pubmed: 25141224
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14
pubmed: 23221186
PLoS Pathog. 2015 Sep 03;11(9):e1005132
pubmed: 26334306
J Infect Dis. 1990 Jul;162(1):82-90
pubmed: 2113080
Lett Appl Microbiol. 2014 Apr;58(4):384-92
pubmed: 24354719
J Clin Invest. 2010 Dec;120(12):4332-41
pubmed: 21099116
J Infect Dis. 2005 Mar 15;191(6):949-56
pubmed: 15717271
J Infect Dis. 2008 Jun 15;197(12):1728-36
pubmed: 18462135
J Immunol. 2012 Jul 1;189(1):296-303
pubmed: 22664870
Infect Immun. 2018 Nov 20;86(12):
pubmed: 30224553
Clin Infect Dis. 2012 Oct;55(7):905-14
pubmed: 22718773
Nature. 2013 Feb 7;494(7435):116-20
pubmed: 23334413
J Clin Invest. 2011 Dec;121(12):4787-95
pubmed: 22045567
Front Immunol. 2017 Dec 22;8:1890
pubmed: 29375557
Infect Immun. 2008 Sep;76(9):4110-9
pubmed: 18591238
Cell Host Microbe. 2014 Oct 8;16(4):504-16
pubmed: 25263220
Infect Immun. 2014 Dec;82(12):5132-42
pubmed: 25267834
J Infect Dis. 1999 Aug;180(2):384-90
pubmed: 10395853
J Clin Invest. 1983 Sep;72(3):1168-71
pubmed: 6411768
Crit Care Med. 2004 Feb;32(2):467-71
pubmed: 14758165
J Med Microbiol. 2001 Aug;50(8):695-701
pubmed: 11478673
J Infect Dis. 2015 Jan 1;211(1):62-71
pubmed: 25035517
J Clin Microbiol. 2004 Mar;42(3):1149-54
pubmed: 15004067
Sci Rep. 2018 Jan 29;8(1):1749
pubmed: 29379180
Curr Microbiol. 1997 Jan;34(1):6-11
pubmed: 8939794
Proc Natl Acad Sci U S A. 1978 Jul;75(7):3479-83
pubmed: 98769
Intensive Care Med. 2018 Aug;44(8):1203-1211
pubmed: 29936583